Nanjing University of Aeronautics and Astronautics, Nanjing, Jiangsu, China; Department of Situation and Policy, Huaibei Normal University, Tuohedong Road, Huaibei 235000, Anhui, China.
Health Policy. 2024 Mar;141:104996. doi: 10.1016/j.healthpol.2024.104996. Epub 2024 Jan 21.
During the COVID-19 pandemic, there was an apparent conflict between medical and political ethics regarding the ethical evaluation of vaccine nationalism - the "My Country First" vaccine allocation policy. Medical ethics sees this policy as selfish, leading to an unequal global vaccine allocation. Political ethics, however, argues that this policy is in the national interest and should not be labeled unethical. This conflict is one of the fundamental reasons why various medical ethics-based global vaccine allocation schemes, including the COVID-19 Vaccines Global Access Facility, have been difficult to implement. As long as the international community remains composed of different countries, vaccine nationalism will be difficult to eradicate. Therefore, international organizations, including World Health Organization, should focus on universal vaccine access rather than allocation based solely on medical ethics. Countries, especially low-income countries, must strengthen vaccine-related capacity-building to immunize their citizens as early as possible. Otherwise, they may still be at the bottom of the global vaccine allocation queue when the next globally challenging outbreak occurs. High-income countries should work to expand the distribution of vaccines, including donating vaccines to countries that lack them, helping other countries set up vaccine factories, and sharing vaccine production technology and intellectual property, which is the right choice from medical and political ethics perspectives.
在 COVID-19 大流行期间,疫苗民族主义(即“我的国家优先”疫苗分配政策)的伦理评估存在明显的医学伦理和政治伦理冲突。医学伦理认为这种政策是自私的,导致全球疫苗分配不平等。然而,政治伦理认为,这种政策符合国家利益,不应该被贴上不道德的标签。这种冲突是各种基于医学伦理的全球疫苗分配方案(包括 COVID-19 疫苗全球获取机制)难以实施的根本原因之一。只要国际社会仍然由不同的国家组成,疫苗民族主义就难以根除。因此,世界卫生组织等国际组织应关注普遍获得疫苗,而不仅仅是基于医学伦理进行分配。各国,特别是低收入国家,必须加强与疫苗相关的能力建设,尽快为其公民接种疫苗。否则,在下一次全球挑战爆发时,它们仍可能处于全球疫苗分配队列的底部。高收入国家应努力扩大疫苗分发,包括向缺乏疫苗的国家捐赠疫苗,帮助其他国家建立疫苗工厂,并分享疫苗生产技术和知识产权,这从医学和政治伦理的角度来看是正确的选择。